Chemed Q2 Adj EPS $4.71 Misses $5.09 Estimate, Sales $553.82M Miss $562.54M Estimate
Portfolio Pulse from saritha@benzinga.com
Chemed (NYSE:CHE) reported Q2 earnings of $4.71 per share, missing the analyst consensus estimate of $5.09 by 7.47%. This is a 2.69% decrease from the same period last year. The company also reported quarterly sales of $553.82 million, missing the analyst consensus estimate of $562.54 million by 1.55%. However, this is a 4.30% increase from the same period last year.
July 26, 2023 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemed's Q2 earnings and sales missed estimates, which could negatively impact its stock price in the short term.
Chemed's earnings and sales for Q2 missed analyst estimates, which is typically seen as a negative signal by the market. This could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100